Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ® Monitor
Launched by HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY · Nov 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device that measures muscle relaxation during surgery, specifically looking at how well it works compared to a standard device called the TOF Watch®-SX. Muscle relaxation is important for certain surgeries, and the trial aims to see if this new device, which combines two types of monitoring technologies, can provide accurate information about muscle relaxation without the complicated setup that other devices often require.
To be eligible for this trial, participants must be under 18 years old, be in good health (with a physical status of I to III), and be scheduled for elective surgery that requires muscle relaxation. Participants will need to voluntarily agree to take part and sign a consent form. Those with certain medical conditions, such as neuromuscular disorders or a history of allergic reactions to muscle relaxants, will not be included. If you choose to participate, you can expect to help researchers understand whether this new device can improve the safety and effectiveness of monitoring muscle relaxation during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age less than 18 yr
- • American Society of Anesthesiologists Physical Status I to III
- • Elective surgery requiring muscle relaxation
- • Patients participated voluntarily and signed informed consent
- Exclusion Criteria:
- • Patients with known neuromuscular disorder
- • Stroke
- • Patients with a history of allergic reaction toneuromuscular blocking agents
- • Use of medications that might interfere with neuromuscular transmission
- • Any previous injury to the examined arm that might influence nerve conduction parameters
- • Pacemaker
About Huazhong University Of Science And Technology
Huazhong University of Science and Technology (HUST) is a prestigious research university located in Wuhan, China, renowned for its commitment to advancing scientific knowledge and innovation in various fields, including medicine and healthcare. With a strong emphasis on interdisciplinary collaboration, HUST engages in cutting-edge clinical research aimed at improving patient outcomes and driving advancements in medical science. The university's clinical trial initiatives are supported by state-of-the-art facilities and a team of experienced researchers, making it a key player in the development of novel therapies and treatment strategies in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Wuhan, Hubei, China
Patients applied
Trial Officials
Hua Zheng, Dr.
Study Director
Department of Anesthesiology, Tongji Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials